Latest filing published 31 Jan 2024 for MaxCyte Inc., €125.
Filing timeline
BuySaleInsider track record
John Johnston: trading record in brief
John Johnston appears in our data through filings on MaxCyte Inc. shares, published by RNS (LSE). Altogether 2 filings, all relating to 26 January 2024.
Sales make up the whole of the open-market record (1 sale, €301). Other entries cover 1 option exercise.
On 31 January 2024 came the latest disclosure, an option exercise for €125 in MaxCyte Inc. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by RNS (LSE). They describe what insiders did and are not a recommendation.
Companies and markets linked to John Johnston
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,000 shares@ £0.021429.4% of flowUS Stock Exchange, NasdaqRNS:5050357-0
- 5,000 shares@ £0.051570.6% of flowUS Stock Exchange, NasdaqRNS:5050357-1
2 of 2 declarations